About Craniosynostosis-microretrognathia-severe intellectual disability syndrome
Craniosynostosis-microretrognathia-severe intellectual disability syndrome is a rare disease catalogued by Orphanet (ORPHA:565858). It is associated with the PPP3CA gene. Search below for active recruiting clinical trials from ClinicalTrials.gov, or visit the Orphanet expert page for specialist centres, natural history studies, and patient registries.
Clinical Trial Eligibility Tips
What to know before applying to Craniosynostosis-microretrognathia-severe intellectual disability syndrome trials.
Search ClinicalTrials.gov for "Craniosynostosis-microretrognathia-severe intellectual disability syndrome" or filter by Orphanet code ORPHA:565858 to find disease-specific studies.
Ask your specialist to refer you to a Centre of Expertise — Orphanet lists all accredited centres for this condition worldwide.
Natural history studies and patient registries often enrol before drug trials open — contact the Orphanet patient community first.
Patient Resources
Find recruiting Craniosynostosis-microretrognathia-severe intellectual disability syndrome trials
Search 500,000+ studies from ClinicalTrials.gov, filtered for Craniosynostosis-microretrognathia-severe intellectual disability syndrome. Updated daily.